Buvalor 20mcg Patch

Introduction to Buvalor 20mcg Patch

Buvalor 20mcg patch contains an active component as Buprenorphine transdermal patch. It is a medication used to manage moderate to severe chronic pain as part of opioid dependence treatment. It provides continuous delivery of buprenorphine, a partial opioid agonist, through the skin into the bloodstream over a period of time. The patch helps maintain a steady blood level of medication, reducing the risk of misuse or diversion. The transdermal delivery system bypasses the gastrointestinal tract, reducing the likelihood of common opioid-related side effects such as nausea and vomiting. Additionally, the controlled release of buprenorphine may result in a reduced incidence of certain side effects. The simplicity of using a patch can enhance treatment adherence, as it eliminates the need for frequent dosing and reduces the chances of missing a dose. This can be especially advantageous for individuals with complex medication regimens or those who have difficulty swallowing pills.

If you have a known hypersensitivity or allergy to this medication or any of the components of the patch, its use is contraindicated. It should be used cautiously in individuals with respiratory conditions, such as chronic obstructive pulmonary disease (COPD), as it can affect respiratory function. This medication can potentially cause or worsen paralytic ileus, a condition characterized by impaired bowel motility. It should be used with caution in individuals at risk for bowel obstruction. Compared to immediate-release oral opioids, the patch may have a slower onset of action, meaning it may take some time to achieve pain relief. Similarly, the effects may persist even after the patch is removed, which can be a disadvantage in case of adverse reactions.

Therapeutic Effects of Buvalor 20mcg Patch

The Buvalor 20mcg patch provides a therapeutic effect by delivering a continuous and controlled release of buprenorphine into the bloodstream. As a partial opioid agonist, this medication binds to opioid receptors in the brain, producing analgesic (pain-relieving) effects for individuals with chronic pain and reducing withdrawal symptoms and cravings in those undergoing opioid dependence treatment.

Interaction of Buvalor 20mcg Patch with other drugs

Inform the doctor about your medicines, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Buvalor 20mcg patch, reducing effectiveness by causing undesirable side effects.

More Information about Buvalor 20mcg Patch

Stored in the temperature between 20°C to 25°C (68°F to 77°F).
Keep away from moisture, heat, and light.
It should not be frozen.
Keep away from children and pets.

How to consume Buvalor 20mcg Patch

To use the Buvalor 20mcg patch, clean and dry the desired application site on the upper arm, chest, back, or side. Avoid areas with broken or irritated skin. Open the patch package and remove the protective liner, being careful not to touch the adhesive. Apply the patch firmly to the skin, ensuring good contact. Press down on the patch for about 30 seconds to secure it in place. Change the patch as directed by your healthcare provider, typically every 7 days.

Safety Advices for Buvalor 20mcg Patch

Pregnancy

If you are pregnant or planning to become pregnant, it is crucial to inform your healthcare provider. They can evaluate your circumstances, weigh the potential risks and benefits, and provide guidance specific to your situation.

Breast Feeding

When it comes to the safety of using the Buvalor 20mcg patch while breastfeeding, it is important to consult with a healthcare professional.

Lungs

Buprenorphine, like other opioids, can cause respiratory depression and a decrease in breathing rate and depth. In individuals with pre-existing lung conditions, such as chronic obstructive pulmonary disease (COPD) or asthma, the risk of respiratory depression may be heightened.

Liver

Buprenorphine is primarily metabolized in the liver, and liver impairment can affect the metabolism and clearance of medications. In individuals with liver conditions, such as cirrhosis or hepatitis, the levels of buprenorphine in the body may be altered.

Alcohol

Both buprenorphine and alcohol can cause central nervous system depression, leading to sedation, impaired cognitive function, and respiratory depression. When used together, the effects can be additive, potentially increasing the risk of severe respiratory depression and other adverse effects.

Driving

The use of the Buvalor 20mcg patch can affect driving and operating machinery due to its potential to cause sedation and impair cognitive and motor function.

Side Effects of Buvalor 20mcg Patch

Buvalor 20mcg patch causes some side effects like all medications, although not everyone will experience them.

Serious:

Difficulty breathing or shortness of breath
Severe drowsiness or sedation
Slowed or irregular heartbeat
Allergic reactions, such as rash, hives, or swelling of the face, lips, or throat
Mental or mood changes
Signs of liver problems (yellow skin or eyes, dark urine, or persistent abdominal pain)

Common:

Nausea and vomiting
Constipation
Drowsiness or sedation
Headache
Sweating
Skin reactions at the patch application site, such as itching, redness, or irritation

Recently Viewed